177 Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) is now approved for patients
with advanced gastroenteropancreatic neuroendocrine tumors (NET), and it is therefore …

Neuroendocrine tumors (NETs) arise from enterochromaffin cells found in neuroendocrine
tissues, with most occurring in the gastrointestinal tract. The global incidence of NETs has …

This article is the result of the North American Neuroendocrine Tumor Society consensus
conference on the medical management of pancreatic neuroendocrine tumors from July 19 to …

Neuroendocrine neoplasms (NEN) are a family of malignancies of diverse origin, including
the lung, gastrointestinal tract, and pancreas. Lung NEN include well differentiated …

Objectives The objective of this study was to describe the outcomes of patients in the
University of Iowa Neuroendocrine Tumor (NET) Database treated with peptide receptor …

Objective We compared the clinical outcomes of patients with metastatic neuroendocrine
tumors treated with hepatic artery embolization (HAE), chemoembolization (HACE), and …

Patients with neuroendocrine tumors (NETs) and carcinoid syndrome experience diarrhea
that can have a debilitating effect on quality of life. Diarrhea also may develop in response to …

Although neuroendocrine tumors (NET) are a relatively rare malignancy, the reported
incidence is increasing, and some of the current treatment options are limited in their efficacy. …

Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a complex and
heterogenous family of solid malignancies that originate from neuroendocrine tissue in the …

Objective To show that traumatic neuroma of the tympanic (Jacobson's) nerve may be a
cause of recurrent intractable otalgia in patients following radical mastoidectomies. Study …